Research Square (Research Square),
Journal Year:
2023,
Volume and Issue:
unknown
Published: Dec. 6, 2023
Abstract
Multisystem
inflammatory
syndrome
in
children
(MIS-C)
has
been
reported
patients
with
inborn
errors
of
immunity
(IEI),
providing
insights
into
disease
pathogenesis.
Here,
we
present
the
first
case
MIS-C
a
child
affected
by
Wiskott-Aldrich
(WAS)
gene
mutation,
elucidating
underlying
predisposing
factors
and
involved
pathways.
Genetic
analysis
revealed
frameshift
truncating
variant
WAS
gene,
resulting
protein
expression
between
mild
severe
forms,
despite
clinical
phenotype
resembling
X-linked
thrombocytopenia
(XLT).
IL-1β
secretion
LPS-stimulated
peripheral
blood
mononuclear
cells
from
patient
during
was
lower
compared
to
healthy
subjects
but
increased
follow-up.
Conversely,
percentage
ASC
(apoptosis-associated
speck-like
containing
CARD)
specks
patient's
circulating
monocytes
acute
phase
higher
than
subjects.
The
type
I
interferon
(IFN)
score
normal,
contrast
raised
IFN
signature
measured
far
event.
This
confirms
association
IEI
MIS-C,
potentially
linked
delayed
immune
responses
SARS-CoV-2.
XLT
underlies
subclinical
immunodysregulation
involving
NLRP3
inflammasome
type-I
response.
The Journal of Experimental Medicine,
Journal Year:
2024,
Volume and Issue:
221(2)
Published: Jan. 4, 2024
We
found
that
19
(10.4%)
of
183
unvaccinated
children
hospitalized
for
COVID-19
pneumonia
had
autoantibodies
(auto-Abs)
neutralizing
type
I
IFNs
(IFN-α2
in
10
patients:
IFN-α2
only
three,
plus
IFN-ω
five,
and
IFN-α2,
IFN-β
two;
nine
patients).
Seven
(3.8%)
Abs
at
least
ng/ml
one
IFN,
whereas
the
other
12
(6.6%)
100
pg/ml.
The
auto-Abs
neutralized
both
unglycosylated
glycosylated
IFNs.
also
detected
pg/ml
4
2,267
uninfected
(0.2%)
45
(2%).
odds
ratios
(ORs)
life-threatening
were,
therefore,
higher
(OR
[95%
CI]
=
67.6
[5.7-9,196.6])
than
2.6
[1.2-5.3]).
ORs
were
high
concentrations
12.9
[4.6-35.9])
those
low
5.5
[3.1-9.6])
and/or
IFN-α2.
Annual Review of Immunology,
Journal Year:
2024,
Volume and Issue:
42(1), P. 615 - 645
Published: June 28, 2024
The
COVID-19
pandemic
was
caused
by
the
recently
emerged
β-coronavirus
SARS-CoV-2.
SARS-CoV-2
has
had
a
catastrophic
impact,
resulting
in
nearly
7
million
fatalities
worldwide
to
date.
innate
immune
system
is
first
line
of
defense
against
infections,
including
detection
and
response
Here,
we
discuss
mechanisms
that
sense
coronaviruses,
with
focus
on
infection
how
these
protective
responses
can
become
detrimental
severe
cases
COVID-19,
contributing
cytokine
storm,
inflammation,
long-COVID,
other
complications.
We
also
highlight
complex
cross
talk
among
cytokines
cellular
components
system,
which
aid
viral
clearance
but
contribute
inflammatory
cell
death,
organ
damage
pathogenesis.
Furthermore,
evades
key
enhance
its
virulence
pathogenicity,
as
well
immunity
be
therapeutically
targeted
part
vaccination
treatment
strategy.
Overall,
comprehensive
understanding
been
crucial
fight
infections
development
novel
host-directed
immunotherapeutic
strategies
for
various
diseases.
Journal of Biological Chemistry,
Journal Year:
2023,
Volume and Issue:
299(8), P. 104960 - 104960
Published: June 24, 2023
A
novel
coronavirus
now
known
as
SARS-CoV-2
emerged
in
late
2019,
possibly
following
a
zoonotic
crossover
from
present
bats.
This
virus
was
identified
the
pathogen
responsible
for
severe
respiratory
disease,
disease-19
(COVID-19),
which
of
May
2023,
has
killed
an
estimated
6.9
million
people
globally
according
to
World
Health
Organization.
The
interferon
(IFN)
response,
cornerstone
antiviral
innate
immunity,
plays
key
role
determining
outcome
infection
by
SARS-CoV-2.
review
considers
evidence
that
leads
IFN
production;
replication
is
sensitive
action;
molecular
mechanisms
antagonizes
and
how
genetic
variability
human
host
affects
response
at
level
production
or
action
both.
Taken
together,
current
understanding
suggests
deficiency
effective
important
determinant
underlying
some
cases
critical
COVID-19
disease
IFNλ
IFNα/β
have
potential
therapeutics
treatment
infection.
Journal of Clinical Immunology,
Journal Year:
2024,
Volume and Issue:
44(8)
Published: Aug. 5, 2024
Abstract
Advanced
genomic
technologies
such
as
whole
exome
or
genome
sequencing
have
improved
diagnoses
and
disease
outcomes
for
individuals
with
genetic
diseases.
Yet,
variants
of
unknown
significance
(VUS)
require
rigorous
validation
to
establish
causality
modification,
exclude
them
from
further
analysis.
Here,
we
describe
a
young
individual
Polynesian
ancestry
who
in
the
first
13
mo
life
presented
SARS-CoV-2
pneumonia,
severe
enterovirus
meningitis
adenovirus
gastroenteritis,
adverse
reaction
MMR
vaccination.
Genomic
analysis
identified
previously
reported
pathogenic
homozygous
variant
IFNAR1
(c.1156G
>
T,
p.Glu386*
LOF),
which
is
common
Western
Polynesia.
Moreover,
new
putatively
deleterious
canonical
splice
site
DOCK8
was
also
found
homozygosity
(c.3234
+
2T
C).
This
Polynesians
other
under-represented
ancestries
large
databases.
Despite
silico
bioinformatic
predictions,
extensive
vitro
ex
vivo
revealed
likely
be
neutral.
Thus,
our
study
reports
novel
case
deficiency,
but
highlights
importance
functional
VUS,
including
those
predicted
deleterious,
pressing
need
expand
knowledge
architecture
landscape
populations
ancestries.
COVID,
Journal Year:
2023,
Volume and Issue:
3(5), P. 773 - 776
Published: May 19, 2023
Coronavirus
disease
2019
(COVID-19),
a
life-threatening
infectious
caused
by
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2),
was
first
identified
in
the
Chinese
city
of
Wuhan
late
and
has
subsequently
spread
worldwide,
reaching
pandemic
proportions
[...]
Severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
induces
pneumonia
and
failure
in
Coronavirus
Disease
2019
(COVID-19)
patients
with
inborn
errors
of
immunity
to
type
I
interferon
(IFN-I).
The
impact
SARS-CoV-2
infection
varies
widely,
ranging
from
mild
symptoms
life-threatening
illness
organ
failure,
a
higher
incidence
men
than
women.
Approximately
3
5%
critical
COVID-19
under
60
smaller
percentage
elderly
exhibit
genetic
defects
IFN-I
production,
including
X-chromosome-linked
TLR7
autosomal
TLR3
deficiencies.
Around
15
20%
cases
over
70
years
old,
younger
patients,
present
preexisting
autoantibodies
neutralizing
interferons.
Additionally,
innate
affecting
the
control
response
have
been
associated
pediatric
multisystem
inflammatory
(MIS-C).
Several
studies
described
rare
immunity,
such
as
XIAP
deficiency,
CYBB,
SOCS1,
OAS1/2,
RNASEL,
underlying
factors
MIS-C
susceptibility.
However,
further
investigations
expanded
patient
cohorts
are
needed
validate
these
findings
pave
way
for
new
approaches
MIS-C.
This
review
aims
recent
evidence
scientific
literature
on
immunological
abnormalities
predisposing
individuals
through
IFN-I.
We
will
also
discuss
children
Understanding
mechanisms
pathogenesis
severe
may
inform
personalized
care
population
protection
strategies
against
future
serious
viral
infections.
Diagnostics,
Journal Year:
2023,
Volume and Issue:
13(13), P. 2151 - 2151
Published: June 23, 2023
The
exact
etiopathogenesis
of
Kawasaki
disease
(KD),
the
most
common
childhood
vasculitis,
remains
unknown;
however,
an
aberrant
immune
response,
possibly
triggered
by
infectious
or
environmental
agent
in
genetically
predisposed
children,
is
believed
to
be
underlying
pathogenetic
mechanism.
Patients
with
inborn
errors
immunity
(IEI)
are
infections
that
trigger
dysregulation
due
imbalance
various
arms
system.
KD
may
develop
as
a
complication
both
primary
and
secondary
immunodeficiencies.
occur
either
at
presentation
have
later
onset
IEIs.
These
include
X-linked
agammaglobulinemia
(XLA),
selective
IgA
deficiency,
transient
hypogammaglobulinemia
infancy;
Wiskott–Aldrich
syndrome
(WAS),
hyper
IgE
(HIES);
chronic
granulomatous
(CGD),
innate
intrinsic
defects,
autoinflammatory
diseases,
including
PFAPA.
Hitherto,
association
between
IEI
confined
specific
case
reports
series
and,
thus,
requires
extensive
research
for
comprehensive
understanding
pathophysiological
mechanisms.
IEIs
serve
excellent
models
would
open
new
insights
into
pathogenesis
children
affected
KD.
current
review
highlights
this
critical
supported
published
literature.
Pediatric Reports,
Journal Year:
2023,
Volume and Issue:
15(2), P. 341 - 348
Published: May 26, 2023
Multisystemic
inflammatory
syndrome
(MIS-C)
is
an
condition
temporally
associated
with
COVID-19
in
children;
nevertheless,
the
clinical
and
immunologic
spectrum
of
MIS-C
heterogeneous,
its
long-term
effects
are
unknown.
During
period
August
2020
to
December
2021,
a
total
52
cases
were
confirmed
pediatric
patients
from
Hospital
del
Niño
DIF
Hidalgo,
diagnosed
using
criteria
World
Health
Organization.
All
had
serologic
IgG
confirmation
SARS-CoV2,
mean
age
was
7
years,
94%
did
not
have
previous
underlying
disease.
In
addition
presentation
lymphopenia,
neutropenia,
thrombocytopenia,
elevations
D-dimer
ferritin
levels
observed
all
patients.
There
improvement
intravenous
gamma
globulin
corticosteroid
treatment.